CSI Market
Sign In | Register

Generation Bio Co (GBIO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GBIO Annual Cash Flow →
Reviewing cash flow figures over time highlights how Generation Bio Co balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
9 Months 		(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Operating Activities
Income-41.25
Depreciation & amortization3.67
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-9.04
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment1.91
Share-based Compensation5.68
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Investment Income Net Amortization Of Discount And Premium-2.58
Increase Decrease In Operating Lease Right Of Use Assets2.88
Increase Decrease In Operating Lease Liability-44.30
Increase Decrease In Tenant Improvements Allowance Receivable-
Gain Loss On Termination Of Lease Non Cash-23.84
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable, Related Parties0.83
Increase (Decrease) in Accounts Payable0.73
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities3.20
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets3.91
Other Working Capital0.32
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-97.87
Investing Activities
Capital Expenditures-0.71
Sale of Capital Items0.48
Proceeds from Sale and Maturity of Marketable Securities110.00
Payments to Acquire Marketable Securities-66.33
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities43.44
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-78.31
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents78.45
Capital Expenditures Incurred But Not Yet Paid-
Marketable Securities Unrealized Gain Loss-0.15
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.07
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-98.10
Total Cash Flow-54.36
4 historic quarters locked

Sign in to unlock the full Generation Bio Co cash flow history.

Sign In Create Free Account

About Generation Bio Co Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-25-107006

Figures are derived from filed reports and may be restated. Historical data is subject to revision.